Azithromycin is an azalide macrolide antibiotic that inhibits bacterial 50S ribosomal protein synthesis, valued for its long tissue half-life enabling short, convenient dosing courses for respiratory and sexually transmitted infections. Simson Pharma's Azithromycin reference standard and impurities support the high-volume compendial testing this widely prescribed antibiotic requires.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Azithromycin Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.